Repotrectinib from MedChemExpress

Product Specs
ItemRepotrectinib
CompanyMedChemExpress
Price $121.00Supplier Page View Company Product Page
Catalog NumberHY-103022
Quantity10 mM * 1 mL
ApplicationsBioactivity, Structure and function analysis, ELISA, SDS-PAGE, Western blotting
Purity99.93%
TypeChemical
Molecular Weight355.37
FormulaC₁₈H₁₈FN₅O₂
Research AreaCancer

Add to Compare List

MedChemExpress

1 Deer Park Drive, Suite F

MONMOUTH JUNCTION, NJ 08852

United States

Phone: US Tel: 609-228-6898
US Fax: 609-228-5909
EU Tel: +4686500910

Email: sales@medchemexpress.com
eu.sales@MedChemExpress.com

Company Profile

Website: medchemexpress.com

(1) Zidesamtinib Selective Targeting of Diverse ROS1 Drug-Resistant MutationsMolecular Cancer TherapeuticsJuly 2, 2025Anupong Tangpeerachaikul, Scot Mente, Joe Magrino, Franklin Gu, Joshua C. Horan, Henry E. Pelishtaletrectinib (MedChemExpress, #HY-131003), repotrectinib (Ark Pharm Inc., #AK689211; MedChemExpress, #HY-103022; SelleckChem, #S8583; DC Chemicals, #DC10463), and N-ethyl-N-nitrosourea (ENU; Sigma, #D2650). Zidesamtinib

(2) A novel TRKB-activating internal tandem duplication characterizes a new mechanism of receptor tyrosine kinase activationNPJ Precis OncolMay 10, 2025Lauren M. Brown, Gabor Tax, Pablo Acera Mateos, Antoine de Weck, Steve Foresto, Thomas Robertson, Fatimah Jalud, Pamela Ajuyah, Paulette Barahona, Jie Mao, et al.Receptor,MedChemExpress,HY-101977 Entrectinib,ALK; ROS; Trk Receptor,MedChemExpress,HY-12678 Repotrectinib,ALK; ROS; Trk Receptor,MedChemExpress,HY-103022 Trametinib,MEK,MedChemExpress,HY-10999 Pimasertib,MEK,MedChemExpress,HY-12042 Paxalisib,mTOR; PI3K,MedChemExpress,HY-19962 Ruxolitinib,JAK,MedChemExpress,HY-50856 Dasatinib,Bcr-Abl;

(3) Ex vivo Drug Sensitivity Imaging-based Platform for Primary Acute Lymphoblastic Leukemia CellsBio ProtocAugust 5, 2023Lauren Rowland, Brandon Smart, Anthony Brown, Gino M. Dettorre, Yoshihiro Gocho, Jeremy Hunt, Wenjian Yang, Satoshi Yoshimura, Noemi Reyes, Guoqing Du, et al.nM",10 27,Larotrectinib,MedChemExpress,HY-12866,10 mM,-80 °C,DMSO,"0.1–10,000 nM",10 28,Repotrectinib,MedChemExpress,HY-103022,10 mM,-80 °C,DMSO,"0.1–10,000 nM",10 29,Sorafenib,MedChemExpress,HY-10201,10 mM,-80 °C,DMSO,"0.1–10,000

(4) NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance MutationsCancer discoveryMarch 1, 2023Drilon A, Horan JC, Tangpeerachaikul A, Besse B, Ou SI, Gadgeel SM, Camidge DR, van der Wekken AJ, Nguyen-Phuong L, Acker A, et al.taletrectinib (MedChemExpress, #HY-131003), repotrectinib (Ark Pharm Inc., #AK689211; MedChemExpress, #HY-103022; SelleckChem, #S8583; DC Chemicals, #DC10463), and lorlatinib (Ark Pharm Inc., #AK175603; eNovation

(5) Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-smallcell Lung Cancer Associated With Poor PrognosisEBioMedicineMarch 1, 2018Karachaliou N, Chaib I, Cardona AF, Berenguer J, Bracht JWP, Yang J, Cai X, Wang Z, Hu C, Drozdowskyj A, et al.

Be the First to Write a Review!

Repotrectinib from MedChemExpress

Description

MedChemExpress

Citations (5)

Reviews

Repotrectinib from MedChemExpress

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map